The FY2025 (Dec) proxy of NewAmsterdam Pharma Co names 24 peer companies for pay. Among NewAmsterdam Pharma Co and these peers, CEO pay was 5th highest of 11 and total shareholder return was 7th highest of 11.
5th highest of 11in NewAmsterdam Pharma Co and its pay peers, FY2025 (Dec) by CEO pay:
$6.6M$33.3M
7th highest of 11in NewAmsterdam Pharma Co and its pay peers, FY2025 (Dec) by total shareholder return:
$107$625
Pay peer group, FY2025 (Dec) proxy
| Scholar Rock Holding | ||
| Cogent Biosciences | ||
| Viking Therapeutics | ||
| Madrigal Pharmaceuticals | ||
| Immunovant | ||
| Krystal Biotech | ||
| IDEAYA Biosciences | ||
| Structure Therapeutics | ||
| Vera Therapeutics | ||
| Tarsus Pharmaceuticals | ||
| 4D Molecular Therapeutics, Inc. | Not disclosed | Not disclosed |
| 89bio, Inc. | Not disclosed | Not disclosed |
| Akero Therapeutics, Inc. | Not disclosed | Not disclosed |
| Belite Bio, Inc. | Not disclosed | Not disclosed |
| Biohaven | Not disclosed | Not disclosed |
| Crinetics Pharmaceuticals, Inc. | Not disclosed | Not disclosed |
| Cullinan Oncology, Inc. | Not disclosed | Not disclosed |
| Geron | Not disclosed | Not disclosed |
| Humacyte, Inc. | Not disclosed | Not disclosed |
| Iovance Biotherapeutics, Inc. | Not disclosed | Not disclosed |
| Keros Therapeutics, Inc. | Not disclosed | Not disclosed |
| Pliant Therapeutics, Inc. | Not disclosed | Not disclosed |
| SpringWorks Therapeutics, Inc. | Not disclosed | Not disclosed |
| Summit Therapeutics | Not disclosed | Not disclosed |
24 companies
Changes by year
No proxy on file names a change to the peer group.
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.